10/10/2024
|
Company update: "Gradual recovery ahead with sizable cushion" – Outperform (TP Bt158)
|
08/10/2024
|
Earnings brief: "2QFY24: Beat on non-NII and opex" – Outperform (TP Bt158)
|
26/09/2024
|
Company update: "Preview 2QFY24: Up QoQ, down YoY" – Outperform (TP Bt158)
|
09/07/2024
|
Company update: "The worst is priced in, gradual recovery ahead" – Outperform (TP Bt158)
|
08/07/2024
|
Earnings brief: "1QFY24: Miss on ECL; expect recovery ahead" – Outperform (TP Bt158)
|
21/06/2024
|
Company update: "Headwinds priced in; upgrade to Outperform" – Upgrade to Outperform (TP Bt170)
|
11/04/2024
|
Company update: "AEONTS – Pressured by regulation headwinds" – Neutral (TP Bt170)
|
10/04/2024
|
Earnings brief: "4QFY23: Big beat on lower ECL" – Neutral (TP Bt170)
|
27/03/2024
|
Company update: "Regulatory headwinds ahead" – Neutral (TP Bt163)
|
|
|
|
|
FOLLOW US
SCB's Facbook INVX's Twitter